InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Pelthos Therapeutics Inc.

PTHS Clue Score29
United States Fiscal year ends December CIK 0001919246 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

39
Insider
Date
Role
Action
Shares
Price
Amount
Matthew Pauls
2 Oct 2026
Director
Sold on a plan
786
$21.00
$16.51K
Ezra M Friedberg
2 Oct 2026
Director
Sold on a plan
558
$20.72
$11.56K
Peter Greenleaf
2 Oct 2026
Director
Sold on a plan
797
$21.17
$16.87K
Peter Greenleaf
2 Jul 2026
Director
Sold on a plan
85
$27.27
$2.32K
Peter Greenleaf
2 Jul 2026
Director
Sold on a plan
712
$26.00
$18.51K
Matthew Pauls
2 Jul 2026
Director
Sold on a plan
94
$27.36
$2.57K
Matthew Pauls
2 Jul 2026
Director
Sold on a plan
692
$26.00
$17.99K
Ezra M Friedberg
2 Jul 2026
Director
Sold on a plan
24
$27.33
$655.81
Ezra M Friedberg
2 Jul 2026
Director
Sold on a plan
534
$26.03
$13.90K
Ezra M Friedberg
15 Jun 2026
Director
Sold on a plan
59
$27.94
$1.65K
Ezra M Friedberg
15 Jun 2026
Director
Sold on a plan
224
$27.12
$6.08K
Todd C Davis
11 Jun 2026
Director
Buy
503
$28.73
$14.45K
Todd C Davis
11 Jun 2026
Director
Buy
35,445
$27.80
$985.53K
Knuettel Francis II
22 May 2026
CFO, Treas & Secty
Sell indirect
1,500
$26.84
$40.26K
Peter Greenleaf
2 Apr 2026
Director
Sold on a plan
377
$21.36
$8.05K
Peter Greenleaf
2 Apr 2026
Director
Sold on a plan
420
$20.52
$8.62K
Matthew Pauls
2 Apr 2026
Director
Sold on a plan
371
$21.36
$7.93K
Matthew Pauls
2 Apr 2026
Director
Sold on a plan
415
$20.52
$8.51K
Ezra M Friedberg
2 Apr 2026
Director
Sold on a plan
265
$21.36
$5.66K
Ezra M Friedberg
2 Apr 2026
Director
Sold on a plan
293
$20.51
$6.01K
Richard Malamut
2 Apr 2026
Director
Sold on a plan
280
$21.36
$5.98K
Richard Malamut
2 Apr 2026
Director
Sold on a plan
310
$20.51
$6.36K
Ezra M Friedberg
25 Nov 2025
Director
Sell indirect
2,000
$28.01
$56.01K
Ezra M Friedberg
25 Nov 2025
Director
Sell indirect
1
$28.50
$28.50
Ezra M Friedberg
25 Nov 2025
Director
Sell indirect
2,000
$28.14
$56.27K
Ezra M Friedberg
25 Nov 2025
Director
Sell indirect
5,999
$28.00
$167.97K
Ligand Pharmaceuticals Inc
1 Jul 2025
10% owner
Exercised, kept
1,500,000
$10.00
$15.00M
Todd C Davis
1 Jul 2025
Director
Exercised, kept indirect
1,500,000
$10.00
$15.00M
Knuettel Francis II
1 Jul 2025
Chief Financial Officer
Exercised, kept indirect
10,000
$10.00
$100.00K
Ezra M Friedberg
1 Jul 2025
Director
Exercised, kept indirect
40,000
$10.00
$400.00K
Ezra M Friedberg
1 Jul 2025
Director
Exercised, kept indirect
40,000
$10.00
$400.00K
Knuettel Francis II
13 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
3,500
$0.97
$3.40K
Knuettel Francis II
12 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
1,700
$0.97
$1.65K
Richard Malamut
12 Sep 2024
Director
Buy indirect
10,400
$0.94
$9.82K
Knuettel Francis II
11 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
5,500
$0.94
$5.17K
Knuettel Francis II
10 Sep 2024
CEO, Pres., CFO, Treas & Secty
Buy indirect
6,500
$0.89
$5.79K
Ezra M Friedberg
21 Feb 2024
Director
Exercised, kept indirect
6,992
$4.80
$33.56K
Ezra M Friedberg
21 Feb 2024
Director
Exercised, kept indirect
13,649
$4.80
$65.52K
Todd C Davis
21 Feb 2024
Director
Exercised, kept
29,167
$4.80
$140.00K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 3,206,057
History held since 23 Feb 2024